Form 4: Agilon Health CFO Acquires Shares, RSUs Granted
Statement of Changes in Beneficial Ownership
Agilon Health's Chief Financial Officer, Jeffrey A. Schwaneke, acquired shares and was granted restricted stock units, reflecting ongoing equity-based compensation and ownership.
Summary
- Jeffrey A. Schwaneke, Chief Financial Officer of Agilon Health, Inc., reported transactions on April 1, 2026.
- He acquired 1,662 shares of common stock, with 892 shares held indirectly through a trust.
- Additionally, 75,000 restricted stock units (RSUs) were granted, which vest in three equal installments annually starting April 1, 2026, contingent upon continued employment.
- The reported share amounts reflect a 1-for-25 reverse stock split effective March 30, 2026.
- Tax withholding obligations resulted in the net settlement of some RSUs, with 1,662 shares withheld by the issuer.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, primarily reporting routine insider transactions and compensation adjustments rather than significant strategic shifts or performance indicators.
Positives
- The CFO's acquisition of shares and grant of RSUs indicates continued confidence and investment in the company's future.
- The vesting schedule for RSUs incentivizes long-term commitment from key management.
- The reverse stock split, while not a positive in itself, is a procedural step often taken to improve share price perception or meet exchange listing requirements.
Negatives
- The withholding of shares for tax obligations on RSUs, while standard, represents a reduction in the net shares received by the executive.
Risks
- The continued employment contingency for RSU vesting means that departure from the company prior to vesting would result in forfeiture of those units.
- The reverse stock split could be perceived negatively by the market if not accompanied by fundamental business improvements.
Future Outlook
The grant of restricted stock units with a multi-year vesting schedule suggests a forward-looking compensation strategy aimed at retaining key talent and aligning executive interests with long-term company performance.
Industry Context
StockSavvy.ai notes that insider transactions, such as stock acquisitions and RSU grants, are common within the healthcare services sector as companies use equity-based compensation to attract and retain executive talent. The reverse stock split is a structural adjustment that does not inherently reflect operational performance but may be a precursor to other strategic moves or a response to market conditions.
Stakeholder Impact
- Shareholders: The transactions reflect standard executive compensation practices and do not immediately signal a change in company strategy or financial health. The reverse stock split may impact per-share metrics.
- Employees: The RSU grant incentivizes continued employment for the CFO, aligning their interests with the company's long-term success.
- Management: The CFO is increasing their direct and indirect beneficial ownership, indicating personal investment in the company.
Next Steps
- Vesting of restricted stock units in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
Key Dates
| Date | Description |
|---|---|
| 03/30/2026 | Effective date of the 1-for-25 reverse stock split. |
| 04/01/2026 | Date of transactions including share acquisition and grant of restricted stock units; also the first vesting anniversary for RSUs. |
| 04/03/2026 | Date the Form 4 was signed by the reporting person's attorney-in-fact. |
Keywords
Form 4, SEC Filing, Agilon Health, AGL, Insider Trading, Stock Options, Restricted Stock Units, Executive Compensation, Beneficial Ownership, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.